Results 131 to 140 of about 17,886 (208)

Efficacy and Safety of Tofacitinib in Palmoplantar Pustulosis: A Retrospective Study. [PDF]

Acta Derm Venereol
Lyu S, Xue X, Wang N, Liu H, Zhang F.
europepmc   +1 more source

Tofacitinib for the treatment of palmoplantar pustulosis: A multicenter prospective study. [PDF]

JAAD Int
Tao Y, Min S, Hua H, Xiao-Hong L, Tauseef H, Chirindo CV, Biao T, Yi-Huan J, Cheng Z, Chao C, Jian-Ping W.   +10 more
europepmc   +1 more source

Exploring the relationship between EQ-5D, DLQI and PASI, and mapping EQ-5D utilities: a cross-sectional study in psoriasis from Hungary [PDF]

, 2019
Balogh, Orsolya, Brodszky, Valentin, Gulácsi, László, Herszényi, Krisztina, Herédi, Emese, Holló, Péter, Jókai, Hajnalka, Kárpáti, Sarolta, Péntek, Márta, Remenyik, Éva, Rencz, Fanni, Szegedi, Andrea   +11 more
core   +1 more source

A frameshift variation in the DSP gene causes a novel subtype of atypical epidermolytic palmoplantar keratoderma: Case report. [PDF]

Front Med (Lausanne)
Lin C, Chen H, Lai S, Huang S, Guo Z, Xie L, Zheng W, Lu J, Zeng Z, Wan C, Li L.   +10 more
europepmc   +1 more source

Case Report: Autosomal recessive palmoplantar keratoderma with additional bilateral hearing loss due to a pathogenic frameshift deletion in <i>FAM83G</i>. [PDF]

Front Med (Lausanne)
Mora-Gómez M, Feito M, Gallego-Zazo N, Maseda-Pedrero R, Sobral-Costas TG, Miranda-Alcaraz L, Vásquez-Amell V, Rodríguez-Canó M, Parra A, Cazalla M, Arias P, Silván C, Jiménez-Estrada JA, Ruiz-Pérez VL, Nevado J, Lapunzina P, Tenorio-Castano J.   +16 more
europepmc   +1 more source

Upadacitinib in the treatment of SAPHO syndrome: a case report. [PDF]

Front Immunol
Yang Y, Sun Z, Ge Y.
europepmc   +1 more source

Secukinumab Plus Upadacitinib for the Treatment of Severe Hidradenitis Suppurativa and Associated Immune-Mediated Comorbidities: A Case Series. [PDF]

Dermatol Ther (Heidelb)
Melgosa Ramos FJ, Martínez Ruiz E, Galarreta Pascual M, Sanz-Motilva V, Martorell A.   +4 more
europepmc   +1 more source

Striate palmoplantar keratoderma

Dermatology Online Journal, 2002
openaire   +4 more sources

Deucravacitinib for the treatment of moderate-to-severe palmoplantar pustulosis: Results from an early-terminated open-label trial. [PDF]

JAAD Int
Ramessur R, Chiesa Fuxench ZC, Shin D, Mason JB, Mason AC, Papadopoulos M, de Oliveira Wafae BG, Noe MH, Gelfand JM.   +8 more
europepmc   +1 more source

Dupilumab treatment for Chinese Nagashima-type palmoplantar keratoderma associated with atopic dermatitis: a case report. [PDF]

Front Immunol
Hua C, Cheng H, Chen X.
europepmc   +1 more source